15 Papers
1 Citations
Kai Qin is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Medicine & Pancreatic cancer. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
Yusheng Shi,Jiabin Jin,Weihua Qiu,Yuanchi Weng,Jian Wang,Shulin Zhao,Zhen Huo,Kai Qin,Yue Wang,Hao Chen,Xiaxing Deng,Chenghong Peng,Baiyong Shen +12 more
TL;DR: This cohort study assesses robot-assisted vs open pancreaticoduodenectomy after the learning curve and concludes that the former is more beneficial than the latter.
The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA
Zengyu Feng,Kexian Li,Kai Qin,Juyong Liang,Minmin Shi,Yang Ma,Shiwei Zhao,Huaiyu Liang,Dongni Han,Baiyong Shen,Chenghong Peng,Hao Chen,Lingxi Jiang +12 more
TL;DR: In this paper , a novel LncRNA, LINC00623, was identified, and its diagnostic value was confirmed, as it could discriminate patients with PDAC from patients with benign pancreatic neoplasms and healthy individuals.
Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?
Jiaqiang Zhang,Jiabin Jin,Shi Chen,Jiangning Gu,Yi Zhu,Kai Qin,Qian Zhan,Dongfeng Cheng,Hao Chen,Xiaxing Deng,Baiyong Shen,Chenghong Peng +11 more
TL;DR: Both RDP and LDP are efficacious and safe methods in treating PNETs located in the body or tail of pancreas andRobotic approach offers advantages with less intraoperative blood loss, higher spleen preservation rate and more lymph node harvest.
LncRNA SNHG7 Regulates Mesenchymal Stem Cell Through the Notch1/Jagged1/Hes-1 Signaling Pathway and Influences Folfirinox Resistance in Pancreatic Cancer.
TL;DR: Zhang et al. as discussed by the authors showed that mesenchymal stem cells (MSCs) increased SNHG7 expression in pancreatic cancer cells, promoting the stemness and Folfirinox resistance via the Notch1/Jagged1/Hes-1 signaling pathway.
Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China.
Yang Ma,Jingrui Yang,Kai Qin,Yiran Zhou,Xiayang Ying,Fei Yuan,Minmin Shi,Jiabin Jin,Di Wang,Jiangning Gu,Jiangning Gu,Dongfeng Cheng +11 more
TL;DR: PmRCCs are uncommon, but pancreatic metastasectomy has a relatively good prognosis and may be a good therapeutic choice for patients with PmR CCs, and long-term follow-up is necessary.